Product Information
DEXTROAMP-AMPHET ER 10 MG CAP is a generic product labeled by Amneal Pharmaceuticals of New York LLC, priced at $0.5272 per EA under NDC 00115148701. Its NADAC has been published 509 times since Nov 23, 2016.
FDA first approved this application on Feb 16, 2016. Its Orange Book therapeutic-equivalence code is AB1 — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
DEXTROAMP-AMPHET ER 10 MG CAP
Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate, and Amphetamine SulfateStrength
2.5; 2.5; 2.5; 2.5 mg/1; mg/1; mg/1; mg/1
Manufacturer
Amneal Pharmaceuticals of New York LLCNDC
00115148701
Classification
Generic
Dosage Form
CAPSULE
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
AMPHETAMINE ASPARTATE MONOHYDRATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATEApproval Type
Generic (ANDA)
FDA Application
ANDA076852FDA Approved
2/16/2016
TE Code
AB1
On Market Since
2/16/2016
Pharmacological Classes
Price Statistics
The NADAC for DEXTROAMP-AMPHET ER 10 MG CAP has been published 509 times since Nov 23, 2016, and over the history we have for it it has declined 82.2%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.5272 per EA |
|---|---|
| All-time high | $3.0389 (Feb 15, 2017) |
| All-time low | $0.3703 (Jul 17, 2024) |
| 52-week high | $0.6088 |
| 52-week low | $0.4861 |
| Median price | $0.6896 |
| Average price | $1.1599 |
| Largest weekly change | +63.7% (Aug 21, 2024) |
| Weeks tracked | 509 |
| Tracking since | Nov 23, 2016 |
Generic Alternatives
The matcher finds 3 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 3% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of DEXTROAMP-AMPHET ER 10 MG CAP?
The current National Average Drug Acquisition Cost (NADAC) for DEXTROAMP-AMPHET ER 10 MG CAP, manufactured by Amneal Pharmaceuticals of New York LLC, is $0.5272 per EA (NDC 00115148701), effective Aug 19, 2026.
How has the price of DEXTROAMP-AMPHET ER 10 MG CAP changed over time?
Over the history we have for it, the NADAC for DEXTROAMP-AMPHET ER 10 MG CAP has declined 82.2%. It has been tracked across 509 weekly CMS publications since Nov 23, 2016.
What are the highest and lowest recorded NADAC prices for DEXTROAMP-AMPHET ER 10 MG CAP?
Since Nov 23, 2016, the NADAC for DEXTROAMP-AMPHET ER 10 MG CAP has ranged from a low of $0.3703 (Jul 17, 2024) to a high of $3.0389 (Feb 15, 2017), with a median of $0.6896 per EA.
Are there cheaper alternatives to DEXTROAMP-AMPHET ER 10 MG CAP?
Yes. 3 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, DEXTROAMP-AMPHET ER 10 MG CAP, is $0.5111 per EA — about 3% below DEXTROAMP-AMPHET ER 10 MG CAP.
Who manufactures DEXTROAMP-AMPHET ER 10 MG CAP?
DEXTROAMP-AMPHET ER 10 MG CAP (NDC 00115148701) is labeled by Amneal Pharmaceuticals of New York LLC, and CMS classifies it as a generic product.